Danaher has closed the acquisition, and the mass spec operations will operate under the name AB Sciex. MDS plans to return the majority of proceeds from the sale to shareholders through a share buyback.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.